Hospital News and Research

RSS

Integra LifeSciences third quarter total revenues increase 8.3% to $186.6 million

Integra LifeSciences Holdings Corporation reported its financial results for the third quarter ending September 30, 2010. Total revenues for the third quarter were $186.6 million, reflecting an increase of $14.4 million, or 8.3%, over the third quarter of 2009. Excluding the impact of changes in foreign currency exchange rates, revenues grew 9%.

28 Oct 2010

Improved end-of-life care needed in Canada

Better psychological and spiritual support, improved planning of care and stronger relationships with physicians are necessary to improve end-of-life care in Canada, according to a study by a Queen's University professor.

28 Oct 2010

PCP credits dedicated primary care community for formation of Harvard's new Center

Harvard Medical School's (HMS) establishment of its $30 million Center for Primary Care is a powerful statement of the importance of primary care and the role major medical institutions must play in its transformation, according to Boston-based nonprofit Primary Care Progress (PCP). PCP credits a dedicated and engaged primary care community, partnering with a visionary dean, for the formation of Harvard's new Center.

28 Oct 2010

PFF’s national scientific conference improves clinical understanding of IPF

The Pulmonary Fibrosis Foundation (PFF) today announced that it is establishing a national scientific conference for idiopathic pulmonary fibrosis (IPF) physicians and patients beginning in 2011. IPF Summit 2011 From Bench to Bedside, will be held at the Marriott Magnificent Mile in Chicago, IL on December 1-3, 2011.

28 Oct 2010

Pfizer announces publication of crizotinib data for NSCLC patients in New England Journal of Medicine

Pfizer Inc. announced today the publication of data showing that 57 percent of ALK-positive advanced non-small cell lung cancer (NSCLC) patients treated with crizotinib (PF-02341066), an investigational oral anaplastic lymphoma kinase (ALK) inhibitor, had either a complete (one patient) or partial (46 patients) response to treatment. Data from 82 patients in this Part 2 expansion cohort of the Phase 1 study were published in the October 28 issue of the New England Journal of Medicine.

28 Oct 2010

Researchers develop software tool to study wiring of brains

A team of researchers at the Eindhoven University of Technology has developed a software tool that physicians can use to easily study the wiring of the brains of their patients. The tool converts MRI scans using special techniques to three-dimensional images. This now makes it possible to view a total picture of the winding roads and their contacts without having to operate.

28 Oct 2010

Disinfection cap dispensing 70% isopropyl alcohol effectively disinfects IV needleless connectors

A study and review performed by clinicians of PICC Excellence, Inc. found a disinfection cap that dispenses 70% isopropyl alcohol is effective in disinfecting IV needleless connectors after five minutes. The study shows that if a needleless connector is covered and bathed in alcohol by the disinfection cap, no drying time is required to kill nearly all pathogens on the connector.

28 Oct 2010

Scientists suggest FDA to reevaluate safety of plant-based antioxidants

Scientists are calling for more research on the possibility that some supposedly healthful plant-based antioxidants including those renowned for their apparent ability to prevent cancer may actually aggravate or even cause cancer in some individuals.

28 Oct 2010

Immune system may play a role in cancer therapies: Study

The immune system may play a critical role in ensuring the success of certain types of cancer therapies, according to a new study by researchers at the Stanford University School of Medicine. The research showed treatments that disable cancer-promoting genes called oncogenes are much more successful in eradicating tumors in the presence of a signaling molecule secreted by kind of immune cell called a T helper cell.

28 Oct 2010

The Methodist Hospital Research Institute opens 12-story, 440,000 square foot research facility

The Methodist Hospital Research Institute® (TMHRI) today opened a 12-story, 440,000 square foot research facility dedicated solely to research and equipped with the world's most advanced technology to help research scientists, physicians and engineers cure diseases that afflict today's patients.

28 Oct 2010

JMC Professor wins Karl Storz Lifetime Achievement Award in Endourology

Demetrius H. Bagley, M.D., the Nathan Lewis Hatfield Professor of Urology in the Department of Urology at Jefferson Medical College (JMC) of Thomas Jefferson University was recently honored as the 2010 recipient of the Karl Storz Lifetime Achievement Award in Endourology at the World Congress of Endourology. He is also a full Professor of Radiology.

28 Oct 2010

Even most vulnerable infants can transition to breast-feeding: Study

Pediatric researchers at The Children's Hospital of Philadelphia describe a successful program in which nurses helped mothers attain high rates of breast-feeding in very sick babies--newborns with complex birth defects requiring surgery and intensive care.

28 Oct 2010

World's largest free-standing proton therapy center opens

Hampton University, along with the Honorable Gov. Bob McDonnell and hundreds of guests, celebrated the grand opening of the Hampton University Proton Therapy Institute (HUPTI), the world's largest free-standing proton center, on Thursday.

28 Oct 2010

KCI announces U.S. launch of Skin IQ MCM for pressure ulcers

Kinetic Concepts, Inc. announced today the U.S. launch of Skin IQ Microclimate Manager (Skin IQ MCM) through KCI's Therapeutic Support Systems business. Skin IQ MCM is a for-sale, powered coverlet offering clinicians one of the most effective and intuitive products available for the prevention and management of pressure ulcers.

28 Oct 2010

Epigenomics presents data on Septin9 biomarker clinical study for colorectal cancer at UEGW

Epigenomics AG, the cancer diagnostics company, announced that new data obtained in a clinical study with the Company's proprietary Septin9 biomarker for the blood-based detection of colorectal cancer, were presented yesterday at the 18th United European Gastroenterology Week (UEGW) in Barcelona, Spain.

28 Oct 2010

Calypso Medical initiates clinical study to evaluate tracking technology for lung tumors

Calypso Medical Technologies, Inc., a developer of real-time localization technology used for the precise tracking of tumors, today announced the initiation of the first clinical study to evaluate the use of the Calypso System for tracking lung cancer tumors during radiation delivery, including a new design of the Company's implantable Beacon transponder.

28 Oct 2010

Health Canada approves PRADAX anticoagulant for stroke prevention in AF patients

Boehringer Ingelheim Ltd. today announces that Health Canada has granted approval of PRADAX (dabigatran etexilate), an oral anticoagulant for the prevention of stroke and systemic embolism in adults with atrial fibrillation in whom anticoagulation is appropriate. PRADAX is the first innovative drug approved in Canada in more than two decades to reduce the risk of stroke in Canadians with atrial fibrillation.

28 Oct 2010

New oral drug shrinks IMT sarcoma driven by abnormally activated protein

A new oral drug caused dramatic shrinkage of a patient's rare, aggressive form of soft-tissue cancer that was driven by an abnormally activated protein, physician-scientists from Dana-Farber Cancer Institute report in the Oct. 28 issue of the New England Journal of Medicine.

28 Oct 2010

Mass. hospitals turn away mentally ill kids, Anthem braces for rate hearings, other state news

The Boston Globe reports that children with mental illnesses are "increasingly being turned away from some Massachusetts hospitals' psychiatric wards, a problem the hospital industry acknowledges and blames on insufficient insurance payments to cover treatment of such sick children. … Dr. JudyAnn Bigby, the state's health and human services secretary, said yesterday that hospitals licensed to treat mentally ill children must provide that care if they have sufficient staffing and beds, regardless of the reimbursement rates" (Lazar, 10/27).

28 Oct 2010

Horizon to distribute Hitachi MRI and CT Product Lines in Canada

Hitachi Medical Systems America (HMSA) is pleased to announce that they have signed an agreement with Horizon Medical Services Ltd., in Mississauga, Ontario to be their exclusive MRI and CT sales and service representative in Canada.

28 Oct 2010

Hospital News and Research

Integra LifeSciences third quarter total revenues increase 8.3% to $186.6 million

Improved end-of-life care needed in Canada

PCP credits dedicated primary care community for formation of Harvard's new Center

PFF’s national scientific conference improves clinical understanding of IPF

Pfizer announces publication of crizotinib data for NSCLC patients in New England Journal of Medicine

Researchers develop software tool to study wiring of brains

Disinfection cap dispensing 70% isopropyl alcohol effectively disinfects IV needleless connectors

Scientists suggest FDA to reevaluate safety of plant-based antioxidants

Immune system may play a role in cancer therapies: Study

The Methodist Hospital Research Institute opens 12-story, 440,000 square foot research facility

JMC Professor wins Karl Storz Lifetime Achievement Award in Endourology

Even most vulnerable infants can transition to breast-feeding: Study

World's largest free-standing proton therapy center opens

KCI announces U.S. launch of Skin IQ MCM for pressure ulcers

Epigenomics presents data on Septin9 biomarker clinical study for colorectal cancer at UEGW

Calypso Medical initiates clinical study to evaluate tracking technology for lung tumors

Health Canada approves PRADAX anticoagulant for stroke prevention in AF patients

New oral drug shrinks IMT sarcoma driven by abnormally activated protein

Mass. hospitals turn away mentally ill kids, Anthem braces for rate hearings, other state news

Horizon to distribute Hitachi MRI and CT Product Lines in Canada

Revolutionizing Life Science: An Interview with SCIEX on ASMS, the SCIEX 7500+ System, and AI-Driven Quantitation

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Latest News